Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

被引:2816
作者
Maisonpierre, PC
Suri, C
Jones, PF
Bartunkova, S
Wiegand, S
Radziejewski, C
Compton, D
McClain, J
Aldrich, TH
Papadopoulos, N
Daly, TJ
Davis, S
Sato, TN
Yancopoulos, GD
机构
[1] REGENERON PHARMACEUT INC,TARRYTOWN,NY 10591
[2] BETH ISRAEL DEACONESS MED CTR,BOSTON,MA 02215
[3] HARVARD UNIV,SCH MED,BOSTON,MA 02215
关键词
D O I
10.1126/science.277.5322.55
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Angiogenesis is thought to depend on a precise balance of positive and negative regulation. Angiopoietin-1 (Ang1) is an angiogenic factor that signals through the endothelial cell-specific Tie2 receptor tyrosine kinase. Like Vascular endothelial growth factor, Ang1 is essential for normal vascular development in the mouse. An Ang1 relative, termed angiopoietin-2 (Ang2), was identified by homology screening and shown to be a naturally occurring antagonist for Ang1 and Tie2. Transgenic overexpression of Ang2 disrupts blood vessel formation in the mouse embryo. in adult mice and humans, Ang2 is expressed only at sites of vascular remodeling. Natural antagonists for vertebrate receptor tyrosine kinases are atypical; thus, the discovery of a negative regulator acting on Tie2 emphasizes the need for exquisite regulation of this angiogenic receptor system.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 37 条
  • [1] BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    WELGUS, HG
    THOMPSON, RC
    EISENBERG, SP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) : 1694 - 1697
  • [2] INVIVO PATTERNS OF EXPRESSION OF UROKINASE AND ITS INHIBITOR PAI-1 SUGGEST A CONCERTED ROLE IN REGULATING PHYSIOLOGICAL ANGIOGENESIS
    BACHARACH, E
    ITIN, A
    KESHET, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10686 - 10690
  • [3] Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF scatter factor variant with partial agonist antagonist activity
    Cioce, V
    Csaky, KG
    Chan, AML
    Bottaro, DP
    Taylor, WG
    Jensen, R
    Aaronson, SA
    Rubin, JS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 13110 - 13115
  • [4] Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
    Davis, S
    Aldrich, TH
    Jones, PF
    Acheson, A
    Compton, DL
    Jain, V
    Ryan, TE
    Bruno, J
    Radziejewski, C
    Maisonpierre, PC
    Yancopoulos, GD
    [J]. CELL, 1996, 87 (07) : 1161 - 1169
  • [5] Davis SR, UNPUB
  • [6] DUMONT DJ, 1992, ONCOGENE, V7, P1471
  • [7] DOMINANT-NEGATIVE AND TARGETED NULL MUTATIONS IN THE ENDOTHELIAL RECEPTOR TYROSINE KINASE, TEK, REVEAL A CRITICAL ROLE IN VASCULOGENESIS OF THE EMBRYO
    DUMONT, DJ
    GRADWOHL, G
    FONG, GH
    PURI, MC
    GERTSENSTEIN, M
    AUERBACH, A
    BREITMAN, ML
    [J]. GENES & DEVELOPMENT, 1994, 8 (16) : 1897 - 1909
  • [8] PERMANENT CELL-LINE EXPRESSING HUMAN FACTOR-VIII-RELATED ANTIGEN ESTABLISHED BY HYBRIDIZATION
    EDGELL, CJ
    MCDONALD, CC
    GRAHAM, JB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12): : 3734 - 3737
  • [9] Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
    Ferrara, N
    CarverMoore, K
    Chen, H
    Dowd, M
    Lu, L
    OShea, KS
    PowellBraxton, L
    Hillan, KJ
    Moore, MW
    [J]. NATURE, 1996, 380 (6573) : 439 - 442
  • [10] ANGIOGENESIS IN REPRODUCTIVE TISSUES
    FINDLAY, JK
    [J]. JOURNAL OF ENDOCRINOLOGY, 1986, 111 (03) : 357 - 366